GlassScriptPhysician profile
Raffi Leblebijian
NPI 1376594754
$16,991.12
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10.00 · 2021: $9,450 · 2022: $2,486 · 2023: $1,000 · 2024: $4,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,667 · Honoraria: $1,000 · Food and Beverage: $349 · Gift: $29.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,666.61 |
| Honoraria | $1,000.00 |
| Food and Beverage | $349.07 |
| Gift | $29.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hiossen, INC. | $8,400.00 | 2021 | |
| Dmg America LLC | $4,102.70 | 2021-2023 | Luxatemp |
| Sonendo INC | $3,961.76 | 2024 | Gentlewave G4 Console, Gentlewave Console, Posterior Cleanflow Procedure Instrument With Matrices |
| Ultradent Products INC | $280.86 | 2022 | |
| Zimvie INC. | $114.66 | 2022 | |
| Gc America INC. | $45.79 | 2021-2024 | G-Cem, G-Aenial, G-Premio Bond |
| Straumann USA LLC | $34.97 | 2024 | |
| Elevate Oral Care | $27.36 | 2024 | Advantage Arrest, Fluorimax 5000, Just Right 5000 |
| 3m Company | $13.02 | 2022 | |
| Purelife, LLC | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raffi Leblebijian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.